Assessing the neuro-protective effect of mild cooling in neonates receiving extra-corporeal membrane oxygenation (ECMO)

ISRCTN ISRCTN72635512
DOI https://doi.org/10.1186/ISRCTN72635512
Secondary identifying numbers N/A
Submission date
01/08/2005
Registration date
21/09/2005
Last edited
17/01/2014
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Neonatal Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Study website

Contact information

Prof David Field
Scientific

Professor of Neonatal Medicine
Dept of Health Sciences
University of Leicester
22-28 Princess Road West
Leicester
LE1 6TP
United Kingdom

Phone +44 (0)116 258 7707
Email Df63@le.ac.uk

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Information for females can be found at: http://www.npeu.ox.ac.uk/nest/nest_downloads/NEST_study_information_leaflet_F.pdf Information for males can be found at: http://www.npeu.ox.ac.uk/nest/nest_downloads/NEST_study_information_leaflet_M.pdf
Scientific titleAssessing the neuro-protective effect of mild cooling in neonates receiving extra-corporeal membrane oxygenation (ECMO): a randomised controlled trial
Study acronymNEST Study
Study objectivesDoes cooling neonates requiring extra-corporeal membrane oxygenation (ECMO) to 34°C for the first 48 to 72 hours of their ECMO run result in improved neurodevelopmental outcome at 2 years corrected age?

Please note that as of 11/02/2009 this record was updated to include amended trial dates. The initial trial dates at the time of registration were:
Initial anticipated start date: 01/11/2005
Initial anticipated end date: 30/11/2010

Please note that as of 19/05/10 this record was updated. All updates can be found in the relevant field with the above update date.
Ethics approval(s)Added 11/02/2009: Trent Multi-Centre Research Ethics Committee gave approval on the 9th June 2005 (ref: 05/MRE04/22)
Health condition(s) or problem(s) studiedFully grown newborn babies requiring help with their breathing and circulation.
InterventionBabies receiving ECMO will be randomised to standard ECMO or ECMO with mild cooling.

As of 19/05/10 this trial is now in follow-up phase.

As of 11/07/2012 the recruitment and follow-up phases are complete and the data collected are under analysis.
Intervention typeOther
Primary outcome measureCurrent information as of 19/05/10:
Cognitive score from the Bayley scales of Infant and toddler Development, 3rd edition (Bayley-III) at age of 2 years (24 - 27 months)

Initial information at time of registration:
The Mental Development Index (MDI) of the Bayley scales of the surviving children in each arm of the study at the age of 2 years (24 - 27 months)
Secondary outcome measuresCurrent information as of 19/05/10:
1. Death
2. Neurological optimality score
3. Gross and fine motor score from the Bayley-III
4. Cerebral Palsy
5. Gross motor function classification score (GMFCS)
6. Seizures requiring regular anticonvulsant treatment
7. Visual difficulties not corrected by spectacles
8. Hearing difficulties requiring aids
9. Language: expressive and receptive scores from the Bayley-III
10. Parent Report of Children's Abilities (PARCA-R)
11. Infant Characteristics Questionnaire
12. The Brief Infant-Toddler Social and Emotional Assessment (BITSEA)
13. Measure of growth: height, weight and head circumference
A child will be considered to be functioning within the normal range for age if their results are within the normal range for all Bayley scores and they have a normal neurological examination, normal vision (including with spectacles) and normal hearing (no aids).

Initial information at time of registration:
1. A structured neurological assessment
2. Parent perception of their child’s health at two years of age
3. The Psychomotor Development Index (PDI) from the Bayley scales
4. Visuospatial assessment
5. The Testers rating of child behaviour
Overall study start date03/10/2005
Completion date31/05/2012

Eligibility

Participant type(s)Patient
Age groupNeonate
SexBoth
Target number of participants118
Key inclusion criteriaBabies recruited to the study must be the existing standard criteria for ECMO eligibility.
These include:
1. To be at least 35 weeks gestation
2. To be at least 2000 g birth weight
3. To have no uncontrolled bleeding disorder
4. To have no congenital or acquired central nervous system (CNS) disorder
5. To have undergone no more than 7 consecutive days of high pressure ventilation prior to referral for ECMO
6. To be suffering from a condition which is potentially reversible
7. To have evidence of severe cardio respiratory failure
8. Less than 29 days of age, either sex
Key exclusion criteria1. All neonates referred with diaphragmatic hernia
2. All neonates receiving ECMO for post operative cardiac support

Added 19/05/10:
3. All neonates who have been cooled prior to ECMO
Date of first enrolment03/10/2005
Date of final enrolment31/05/2012

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Professor of Neonatal Medicine
Leicester
LE1 6TP
United Kingdom

Sponsor information

University Hospitals of Leicester NHS Trust (UK)
Hospital/treatment centre

Trust Headquarters
Gwendolin Road
Leicester
LE5 4QF
England
United Kingdom

Phone +44 (0)116 258 4199
Email djr8@le.ac.uk
ROR logo "ROR" https://ror.org/02fha3693

Funders

Funder type

Charity

British Heart Foundation (BHF) (UK) (ref: SP/04/004)
Private sector organisation / Trusts, charities, foundations (both public and private)
Alternative name(s)
the_bhf, The British Heart Foundation, BHF
Location
United Kingdom

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Protocol article protocol 19/04/2010 Yes No
Results article results 01/11/2013 Yes No